Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 54(6): 673-678, 2020 Jun 06.
Article in Chinese | MEDLINE | ID: mdl-32842285

ABSTRACT

Objective: To analyze the correlation between the changes of lung function and serum proinflammatory cytokines in workers occupationally exposed to toluene diisocyanate (TDI), and to explore the evaluation index of respiratory toxicity of TDI. Methods: In October 2014, 61 male workers engaged in TDI synthesis process, purification process, packaging process and the above production process in a TDI factory in western China were selected as TDI exposure group; 62 male enterprise managers who were not exposed to TDI and other known allergenic chemicals were selected as control group, which were matched at the age of workers in exposure group. The questionnaire survey obtained information such as gender, length of service, age, occupational history, exposed length of service and so on. The lung function indexes [forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), FEV1/FVC] and serum levels of interleukin (IL)-1 ß, IL-6, IL-8, tumor necrosis factor (TNF)-α, macrophage inflammatory factor-1 ß, monocyte chemoattractant factor-1 and vascular endothelial growth factor were measured. The urine was collected after the weekend shift, and the concentration of (TDA), the metabolite of TDI, was determined as the index of internal exposure. Spearman rank correlation was used to analyze the correlation between cytokines and lung function indexes, and multivariate linear regression was used to analyze the changes of lung function indexes and cytokines with TDI exposure concentration and time. Results: The median age (P5-P95) of the exposed group and the control group was 36.5 (24.0-51.0) and 38.0 (24.0-50.0) years, respectively. In the exposed group, the median length of service (P5-P95) was 6.94 (0.97-26.33) years, and the median concentration of TDA in urine was 15.56 (2.28-112.16) ng/ml. The three indexes of lung function, FVC, FEV1, FEV1/FVC and the levels of serum IL-8 and TNF-α were significantly lower than those in the control group (P<0.01). With the increase of exposure concentration and exposure time, the level of serum TNF-α, FVC and FEV1 decreased, and showed a good dose-effect and time-effect relationship (all Ptrend values< 0.05). Serum IL-8 and TNF-α were positively correlated with FVC, FEV1 and FEV1/FVC (all P values<0.01). Conclusion: The levels of serum inflammatory factors IL-8 and TNF-α in worker exposed to TDI are related to lung function indexes, which can be used as early evaluation indexes of respiratory toxicity induced by TDI.


Subject(s)
Occupational Exposure , Toluene 2,4-Diisocyanate , Adult , China , Cytokines , Humans , Lung , Male , Middle Aged , Vascular Endothelial Growth Factor A
2.
Zhonghua Kou Qiang Yi Xue Za Zhi ; 53(1): 20-25, 2018 Jan 09.
Article in Chinese | MEDLINE | ID: mdl-29972959

ABSTRACT

Objective: To investigate the distribution of fimA and kgp genotypes as well as the common genotype combination of Porphyromonas gingivalis (Pg) in infected root canals of primary apical periodontitis for virulent isolates screening in future. Methods: Thirty-four samples harboring Pg were selected from infected root canals of primary apical periodontitis from patients of the Department of Endodontics, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine from June 2013 to September 2015. FimA type-specific primers were used to amplify the samples, revealing the distribution of various fimA genotypes. The genotypes of kgp were obtained by using Mse Ⅰ restriction endonuclease. The prevalence of each genotype and common genotype combinations were then calculated. Pearson's chi-squared test was performed to analyze the correlation between genotype combinations and clinical symptoms and major signs of apical periodontitis. In addition, the bioflim architectures between Pg isolates with different fimA and kgp genotype combinations were observed compared using confocal laser scanning microscope. Results: Among the 34 Pg-positive samples, fimA Ⅱ was the most prevalent genotype [47% (16/34)] followed by fimA Ⅰ [26% (9/34)], while fimA Ⅴ was detected in only one sample. The prevalence of kgp Ⅰ [56% (19/34)] was slightly higher than that of kgp Ⅱ [44% (15/34)]. Both fimA Ⅱ+kgp Ⅰ and fimAⅡ+kgp Ⅱ were the most prevalent genotype combinations [24% (8/34) each]. No significant correlation was found between specific genotype combination and such major clinical manifestations as gingival swelling and sinus tract of dental origin (P>0.05). Three Pg isolates with different genotype combinations were acquired. Isolate A (fimAⅠ+kgpⅠ) formed densest biofilm, while the biofilm of isolate C (fimAⅤ+kgp Ⅰ) was much looser. The biofilm feature of isolate B (fimAⅢ+kgp Ⅱ) fell in between A and C. Conclusions: Pg with fimA Ⅱ was most frequently detected in infected root canals of primary apical periodontitis. The prevalence of Pg with kgp Ⅰ was slightly higher than that with kgp Ⅱ, and fimAⅡ+kgp Ⅰ as well as fimA Ⅱ+kgp Ⅱ were the commonest genotype combinations. According to the comparison of Pg biofilms formed by clinical isolates, it might be possible that different genotype combinations may lead to distinct biofilm architectures.


Subject(s)
Adhesins, Bacterial/genetics , Cysteine Endopeptidases/genetics , Dental Pulp Cavity/microbiology , Fimbriae Proteins/genetics , Genotype , Periapical Periodontitis/microbiology , Porphyromonas gingivalis/genetics , Adhesins, Bacterial/metabolism , China , Cysteine Endopeptidases/metabolism , DNA Primers , Fimbriae Proteins/metabolism , Gingipain Cysteine Endopeptidases , Humans , Periapical Periodontitis/metabolism , Polymerase Chain Reaction , Porphyromonas gingivalis/metabolism
3.
Zhonghua Yu Fang Yi Xue Za Zhi ; 51(6): 556-561, 2017 Jun 06.
Article in Chinese | MEDLINE | ID: mdl-28592103

ABSTRACT

Objective: To investigate the association between etheno-DNA adduct and the promoter of DNA methylation levels of cyclin dependent kinase inhibitor 2A (P16), Ras association domain family 1 (RASSF1A) and O-6-methylguanine-DNA methyltransferase (MGMT) in workers with occupational exposure to diesel engine exhaust (DEE). Methods: We recruited 124 diesel engine testing workers as DEE exposure group and 112 water pump operator in the same area as control group in Henan province in 2012 using cluster sampling. The demographic data were obtained by questionnaire survey; urine after work and venous blood samples were collected from each subject. The urinary etheno-DNA adducts were detected using UPLC-MS/MS, including 1,N6-etheno-2'-deoxyadenosine (εdA) and 3,N4-etheno-2'-deoxycytidine(εdC). The DNA methylation levels of P16, RASSF1A, and MGMT were evaluated using bisulfite-pyrosequencing assay. The percentage of methylation was expressed as the 5-methylcytosine (5mC) over the sum of cytosines (%5mC). Spearman correlation and multiple linear regression were applied to analyze the association between etheno-DNA adducts and DNA methylation of P16, RASSF1A, and MGMT. Results: The median (P(25)-P(75)) of urinary εdA level was 230.00 (98.04-470.91) pmol/g creatinine in DEE exposure group, and 102.10 (49.95-194.48) creatinine in control group. The level of εdA was higher in DEE exposure group than control group (P<0.001). DNA methylation levels of P16, RASSF1A and MGMT were 2.04±0.41, 2.19 (1.94-2.51), 2.22 (1.94-2.46)%5mC in exposure group, and 2.19±0.40, 2.41 (2.11-2.67), 2.44 (2.15-2.91)%5mC in control group. DNA methylation levels were lower in exposure group (P values were 0.005, 0.002 and 0.001, respectively). Spearman correlation analysis showed that DNA methylation levels of P16, RASSF1A, and MGMT were negative associated with urinary εdA level (r values were -0.155, -0.137, and -0.198, respectively, P<0.05). No significant correlation was observed between the εdC level and any measured DNA methylation levels (P>0.05) . Multiple linear regression confirmed the negative correlation between εdA and DNA methylation levels of P16, RASSF1A, and MGMT in non-smoking group (ß (95%CI) was -0.068 (-0.132--0.003), -0.082 (-0.159--0.004) and -0.048 (-0.090--0.007), P values were 0.039, 0.039 and 0.024, respectively). Moreover, εdC was negative associated with DNA methylation level of MGMT in non-smoking group (ß (95%CI) was -0.094 (-0.179--0.008), P=0.032). Conclusion: DEE exposure could induce the increased of εdA and decreased of DNA methylation levels of P16, RASSF1A and MGMT.


Subject(s)
DNA Adducts/genetics , DNA Methylation/drug effects , Occupational Exposure/adverse effects , Vehicle Emissions/toxicity , Chromatography, High Pressure Liquid , Cyclin-Dependent Kinase Inhibitor p16/genetics , DNA Damage , DNA Methylation/genetics , Deoxyadenosines , Deoxycytidine , Humans , Male , Occupational Exposure/analysis , Oxidative Stress , Promoter Regions, Genetic , Tandem Mass Spectrometry
4.
Zhonghua Kou Qiang Yi Xue Za Zhi ; 51(12): 728-733, 2016 Dec 09.
Article in Chinese | MEDLINE | ID: mdl-27978913

ABSTRACT

Objective: To establish a digital workflow in the treatment of mandibular condylar osteochondroma with secondary dentofacial deformities using navigation and endoscope combined with orthognathic surgery. Methods: Thirty-six patients with unilateral condylar osteochondroma were analyzed retrospectively. Preoperative planning and simulation were carried out on the digital three-dimansional (3D) model in all patients. With the aid of image-guided endoscopic navigation, osteochondroma resection and condylectomy were accurately performed. Secondary dentofacial deformities were simultaneously corrected using orthognathic surgery. All patients were followed up regularly and received postoperative CT scans. The preoperative simulated model and the postoperative actual model were matched using ProPlan CMF 2.0 software. Four corresponding points were marked in the virtual and actual ostectomy plane, respectively. The intersections of mandibular sigmoid notch and posterior ramusrim with condylectomy plane were marked as the anterior point and the posterior point, respectively. The perpendicular bisector of the line from the anterior point to the posterior point was intersected with the lateral and medial margin of condylectomy plane to form the lateral point and the medial point, respectively. The straight-line distances between the corresponding points in the virtual and actual ostectomy plane were respectively measured to analyze the ostectomy discrepancy. Results: All of 36 patients obtained satisfactory clinical effects. Facial symmetry and morphology were greatly improved. Postoperative CT showed that condylar tumors were completely removed. The preoperative simulated model and the postoperative actual model were matched. The average discrepancy between the planned and actual surgical resection was minimal on the anterior points ([0.24 ± 0.17] mm) and the mean error was maximal on the posterior points ([3.86±1.03] mm). The patients showed no signs of tumor recurrence in the 6 to 12 months of follow-up. Conclusions: Endoscope-assisted and navigation-guided tumor resection and condylectomy combined with simultaneous orthognathic surgery has satisfactory clinical effects in the treatment of condylar osteochondroma and secondary dentofacial deformities. The digital management workflow reported in this paper provides us a valuable option for this potentially complicated procedure.


Subject(s)
Dentofacial Deformities , Mandibular Neoplasms , Osteochondroma , Endoscopy , Humans , Mandible , Mandibular Condyle , Neoplasm Recurrence, Local , Orthognathic Surgery , Retrospective Studies , Tomography, X-Ray Computed , Workflow
5.
Article in Chinese | MEDLINE | ID: mdl-27866544

ABSTRACT

Objective: To investigate the effects of chronic exposure to monochloroacetic acid on the lung function and whole blood counts in occupational exposed workers, and provide new markers for occupational health surveillance. Methods: We conducted a cross-sectional molecular epidemiology study of 121 workers who were occupationally exposed to monochloroacetic acid and 69 unexposed workers frequency-matched by age and smoking status from the same geographic region. The lung function was measured by portable lung function instrument, and the lymphocyte subsets were measured by flow cytometry. Linear regression was used to test for differences in the levels of each marker between exposed and control workers. Results: FEV1.0/FVC was significantly decreased in both male and female workers exposed to monochloroacetic acid compared to unexposed workers (P<0.01) after adjusting for potential confounders, which were highly consistent when stratified by smoking status. Among male workers, monochloroacetic acid exposure was associated with significant decrease in the levels of CD8+ T cells (P<0.05) and monocytes (P<0.05) , and these statistically significant differences were observed between exposure and control workers only among smokers, not among non-smokers. However, there were no significant differences in the levels of whole blood cells and lymphocyte subsets between two groups among female workers. Conclusion: The chronic monochloroacetic acid exposure was associated with pulmonary dysfunction and immunosuppression, which mainly occurred among male workers and smokers.


Subject(s)
Lymphocyte Subsets , Acetates , Cross-Sectional Studies , Female , Humans , Lymphocyte Count , Male , Occupational Exposure
6.
Dose Response ; 5(1): 63-75, 2006 Aug 25.
Article in English | MEDLINE | ID: mdl-18648557

ABSTRACT

The conventional approach for radiation protection is based on the ICRP's linear, no threshold (LNT) model of radiation carcinogenesis, which implies that ionizing radiation is always harmful, no matter how small the dose. But a different approach can be derived from the observed health effects of the serendipitous contamination of 1700 apartments in Taiwan with cobalt-60 (T(1/2) = 5.3 y). This experience indicates that chronic exposure of the whole body to low-dose-rate radiation, even accumulated to a high annual dose, may be beneficial to human health. Approximately 10,000 people occupied these buildings and received an average radiation dose of 0.4 Sv, unknowingly, during a 9-20 year period. They did not suffer a higher incidence of cancer mortality, as the LNT theory would predict. On the contrary, the incidence of cancer deaths in this population was greatly reduced-to about 3 per cent of the incidence of spontaneous cancer death in the general Taiwan public. In addition, the incidence of congenital malformations was also reduced--to about 7 per cent of the incidence in the general public. These observations appear to be compatible with the radiation hormesis model. Information about this Taiwan experience should be communicated to the public worldwide to help allay its fear of radiation and create a positive impression about important radiation applications. Expenditures of many billions of dollars in nuclear reactor operation could be saved and expansion of nuclear electricity generation could be facilitated. In addition, this knowledge would encourage further investigation and implementation of very important applications of total-body, low-dose irradiation to treat and cure many illnesses, including cancer. The findings of this study are such a departure from expectations, based on ICRP criteria, that we believe that they ought to be carefully reviewed by other, independent organizations and that population data not available to the authors be provided, so that a fully qualified epidemiologically-valid analysis can be made. Many of the confounding factors that limit other studies used to date, such as the A-bomb survivors, the Mayak workers and the Chernobyl evacuees, are not present in this population exposure. It should be one of the most important events on which to base radiation protection standards.

7.
Rheumatology (Oxford) ; 42(12): 1529-33, 2003 Dec.
Article in English | MEDLINE | ID: mdl-13130146

ABSTRACT

OBJECTIVE: To elucidate the recent changes in the clinical manifestations, risk factors and disorders associated with gout. METHODS: All gouty cases in Ho-Ping Gout Database were divided into two groups according to the date of first visit to our clinic: 1983-1991 (earlier group) and 1992-1999 (later group). Study variables were compared between these two groups. RESULTS: In the later group, the age at onset of gout was lower by 2.7 yr (P < 0.0001) and the percentages of female gout and familial gout were higher (P = 0.0046 and P < 0.0001, respectively). Joint counts and the percentage of frequency of attacks > or =6 times/yr were lower in the later group (P < 0.0001), while the percentage of tophaceous gout was higher by 0.8% in the later group (P = 0.0004). The percentage of first attack at ankle was higher (P < 0.0001), while those at Achilles tendon, knee and upper extremity were lower in the later group (P < 0.0001). The percentages of diuretic use and alcohol consumption were lower in the later group (P < 0.0001). The percentages of obesity, hypertriglyceridaemia and nephrolithiasis were higher (P < 0.0001), while the percentages of hypertension and hypercholesterolaemia were lower in the later group (P < 0.0001 and P = 0.0003, respectively). The percentages of type 2 diabetes mellitus and renal insufficiency were not significantly different in multivariate analyses. CONCLUSION: The age of onset, clinical manifestations, risk factors and disorders associated with gout have recently changed in Taiwan.


Subject(s)
Gout/etiology , Adolescent , Adult , Age of Onset , Aged , Aged, 80 and over , Alcohol Drinking/adverse effects , Alcohol Drinking/trends , Diuretics/administration & dosage , Diuretics/adverse effects , Female , Gout/epidemiology , Gout/pathology , Humans , Hyperlipidemias/complications , Hyperlipidemias/epidemiology , Hypertension/complications , Hypertension/epidemiology , Kidney Calculi/complications , Kidney Calculi/epidemiology , Male , Middle Aged , Obesity/complications , Obesity/epidemiology , Retrospective Studies , Risk Factors , Sex Distribution , Taiwan/epidemiology
8.
Metabolism ; 50(10): 1203-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11586494

ABSTRACT

We examined whether the age at onset, gender, arthritic manifestations, and tophus formation in familial gout are different from those in nonfamilial gout, and we also examined the contributory effect of genetic association to the concurrence of hypertriglyceridemia, hypercholesterolemia, type 2 diabetes mellitus (DM), hypertension, obesity, and renal insufficiency with gout in Taiwan. A total of 21,373 gout patients' data from Ho-Ping Gout database were analyzed in this study retrospectively. The clinical and laboratory data were compared between familial and nonfamilial gout. Mean age at onset of gout in familial subjects was significantly 7.5 years lower than that of nonfamilial subjects (40.9 +/- 13.4 v 48.4 +/- 14.2 years, P =.0001), while gender, arthritic severity, and tophus formation were not significantly different between these 2 groups. Familial gout had lower serum triglyceride (TG), total cholesterol (TC), and percentage of hypertension than nonfamilial gout (182.4 +/- 125.3 v 195.9 +/- 135.8 mg/dL, P =.0001; 207.5 +/- 42.5 v 210.4 +/- 48.8 mg/dL, P =.0003; and 19.57% v 22.56%, P <.0001, respectively). Their serum creatinine, body mass index (BMI), and percentage of type 2 DM were not significantly different. Our results demonstrate that familial gout is associated with precocious onset. Furthermore, the contributory effect of genetic association to the concurrence of hyperlipidemia and hypertension with gout is less than that of environmental factors, while the effect of genetic association to the concurrence of obesity, type 2 DM, and renal insufficiency with gout is equivalent to that of environmental factors.


Subject(s)
Gout/genetics , Age of Onset , Alcohol Drinking , Body Mass Index , Comorbidity , Creatinine/blood , Cross-Sectional Studies , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/genetics , Female , Gout/epidemiology , Gout/pathology , Humans , Hyperlipidemias/epidemiology , Hyperlipidemias/genetics , Hypertension/epidemiology , Hypertension/genetics , Male , Middle Aged , Obesity/genetics , Retrospective Studies , Sex Factors , Taiwan/epidemiology , Triglycerides/blood , Uric Acid/blood
9.
Chem Biol Interact ; 130-132(1-3): 81-91, 2001 Jan 30.
Article in English | MEDLINE | ID: mdl-11306033

ABSTRACT

Disulfiram (DSF) has found extensive use in the aversion therapy treatment of recovering alcoholics. It is known that DSF or a metabolite irreversibly inhibits aldehyde dehydrogenase (ALDH). However, the actual mechanism of inhibition is still not known. In this work we describe the in vitro interactions of DSF, as well as a principal metabolite S-methyl-N,N-diethylthiocarbamoyl sulfoxide (MeDTC-SO), with both recombinant rat liver mitochondrial monomeric ALDH (rmALDH) and homotetrameric rmALDH. We show that DSF directly inhibits rmALDH (IC(50)=36.4 microM) by inducing the formation of an intramolecular disulfide bond. We also demonstrate by HPLC-MS analysis of a Glu-C digest of DSF-treated rmALDH that the intramolecular disulfide bridge formed involves two of the three cysteines located at the active site of the enzyme. Using a combination of HPLC-MS and HPLC-MS/MS, we further show that the electrophilic metabolite MeDTC-SO also inhibits rmALDH (IC(50)=4.62 microM). We isolate and identify a carbamoylated peptide at Cys(302) with the sequence FNQGQC(301)C(302)C(303). Hence we show that MeDTC-SO exhibits its inhibitory effect by covalently modifying the -SH side-chain of Cys(302), present at the active site rmALDH. Finally we show using SEC-MS that both DSF and MeDTC-SO do not prevent formation of the homotetramer of rmALDH, but inhibit the enzyme by acting directly at the active site of specific monomers of rmALDH.


Subject(s)
Aldehyde Dehydrogenase/antagonists & inhibitors , Disulfiram/pharmacology , Aldehyde Dehydrogenase/chemistry , Aldehyde Dehydrogenase/genetics , Amino Acid Sequence , Animals , Catalytic Domain , Chromatography, High Pressure Liquid , Cysteine/chemistry , Disulfiram/metabolism , Ditiocarb/analogs & derivatives , Ditiocarb/metabolism , Ditiocarb/pharmacology , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Humans , In Vitro Techniques , Mass Spectrometry , Mitochondria, Liver/enzymology , Molecular Sequence Data , Protein Structure, Quaternary , Rats , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry , Recombinant Proteins/genetics
10.
Chem Biol Interact ; 130-132(1-3): 93-102, 2001 Jan 30.
Article in English | MEDLINE | ID: mdl-11306034

ABSTRACT

Disulfiram (DSF) has found extensive use in the aversion therapy treatment of recovering alcoholics. Although it is known to irreversibly inhibit hepatic aldehyde dehydrogenase (ALDH), the specific mechanism of in vivo inhibition of the enzyme by the drug has not yet been determined. In this report, we demonstrate a novel, but simple and rapid method for structurally characterizing in vivo derived protein-drug adducts by linking on-line sample processing to HPLC-electrospray ionization mass spectrometry (HPLC-MS) and HPLC-tandem mass spectrometry (HPLC-MS/MS). Employing this approach, rats were administered DSF, and their liver mitochondria were isolated and solubilized. Both native and in vivo DSF-treated mitochondrial ALDH (rmALDH) were purified in one-step with an affinity cartridge. The in vivo DSF-treated rmALDH showed 77% inhibition in enzyme activity as compared to that of the control. Subsequently, the control and DSF-inhibited rmALDH were both subjected to HPLC-MS analyses. We were able to detect two adducts on DSF-inhibited rmALDH as indicated by the mass increases of approximately 71 and approximately 100 Da. To unequivocally determine the site and structure of these adducts, on-line pepsin digestion-HPLC-MS and HPLC-MS/MS were performed. We observed two new peptides at MH(+)=973.7 and 1001.8 in the pepsin digestion of DSF-inhibited enzyme. These two peptides were subsequently subjected to HPLC-MS/MS for sequence determination. Both peptides possessed the sequence FNQGQC(301)C(302)C(303), derived from the enzyme active site region, and were modified at Cys(302) by N-ethylcarbamoyl (+71 Da) and N-diethylcarbamoyl (+99 Da) adducts. These findings indicated that N-dealkylation may be an important step in DSF metabolism, and that the inhibition of ALDH occurred by carbamoylation caused by one of the DSF metabolites, most likely S-methyl-N,N-diethylthiocarbamoyl sulfoxide (MeDTC-SO).


Subject(s)
Aldehyde Dehydrogenase/antagonists & inhibitors , Disulfiram/pharmacology , Aldehyde Dehydrogenase/chemistry , Aldehyde Dehydrogenase/isolation & purification , Amino Acid Sequence , Animals , Chromatography, High Pressure Liquid , Disulfiram/metabolism , Ditiocarb/analogs & derivatives , Ditiocarb/metabolism , Ditiocarb/pharmacology , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Mitochondria, Liver/enzymology , Pepsin A , Rats , Spectrometry, Mass, Electrospray Ionization
11.
Biochem Pharmacol ; 61(5): 537-45, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11239496

ABSTRACT

Extensive use for disulfiram (DSF) has been found in the aversion therapy treatment of recovering alcoholics. Although it is known to irreversibly inhibit hepatic aldehyde dehydrogenase (ALDH), the specific mechanism of in vivo inhibition of the enzyme by the drug has not been determined yet. We have demonstrated in this report a novel, but simple and rapid method for structurally characterizing in vivo derived protein-drug adducts by linking on-line sample processing to HPLC-electrospray ionization mass spectrometry (HPLC-MS) and HPLC-tandem mass spectrometry (HPLC-MS/MS). Employing this approach, rats were administered DSF, and their liver mitochondria were isolated and solubilized. Both native and in vivo DSF-treated mitochondrial ALDH (mALDH) were purified in one step with an affinity cartridge. The in vivo DSF-treated mALDH showed 77% inhibition in enzyme activity as compared with that of the control. Subsequently, the control and DSF-inhibited mALDH were both subjected to HPLC-MS analyses. We were able to detect two adducts on DSF-inhibited mALDH, as indicated by the mass increases of approximately 71 and approximately 100 Da. To unequivocally determine the site and structure of these adducts, on-line pepsin digestion-HPLC-MS and HPLC-MS/MS were performed. We observed two new peptides at MH(+) = 973.7 and MH(+) = 1001.8 in the pepsin digestion of DSF-inhibited enzyme. These two peptides were subsequently subjected to HPLC-MS/MS for sequence determination. Both peptides possessed the sequence FNQGQC(301)C(302)C(303), derived from the enzyme active site region, and were modified at Cys(302) by N-ethylcarbamoyl (+71 Da) and N-diethylcarbamoyl (+99 Da) adducts. These findings indicated that N-dealkylation may be an important step in DSF metabolism, and that the inhibition of ALDH occurred by carbamoylation caused by one of the DSF metabolites, most likely S-methyl-N,N-diethylthiocarbamoyl sulfoxide (MeDTC-SO). Finally, there was no evidence of the presence of an intramolecule disulfide bridge modification on the peptide FNQGQCCC.


Subject(s)
Alcohol Deterrents/analysis , Aldehyde Dehydrogenase/analysis , Disulfiram/analysis , Mitochondria, Liver/enzymology , Alcohol Deterrents/chemistry , Aldehyde Dehydrogenase/chemistry , Aldehyde Dehydrogenase/metabolism , Amino Acid Sequence , Animals , Chromatography, High Pressure Liquid , Disulfiram/chemistry , Mass Spectrometry , Pepsin A/metabolism , Peptides/analysis , Peptides/chemistry , Protein Processing, Post-Translational , Rats
12.
J Am Soc Mass Spectrom ; 12(1): 97-104, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11142365

ABSTRACT

Aldehyde dehydrogenases (ALDH) are a family of enzymes primarily involved in the oxidation of various aldehydes. Most ALDH enzymes derived from mammalian sources have been shown to exist as homotetramers, consisting of four identical subunits of approximately 54 kDa. The presence of the homotetramer appears to be necessary for enzyme activity. In this study, recombinant rat liver mitochondrial ALDH (rmALDH) was inhibited in vitro with four different inhibitors, namely, disulfiram (MW, 296.5), prunetin (MW, 284.3), benomyl (MW, 290.3), and N-tosyl-L-phenylalanine chloromethyl ketone (TPCK) (MW, 351.8). Subsequently, inhibited rmALDH was analyzed by a novel approach of on-line size exclusion chromatography-microelectrospray ionization-mass spectrometry (SEC-muESI-MS) to examine the noncovalent quaternary structural stability of the inhibited enzyme. Analysis of native rmALDH by SEC-muESI-MS revealed predominantly the homotetramer (Mr = approximately 217,457 Da, +/- 0.01%) with some in-source, skimmer-induced dissociation to afford monomer (Mr = approximately 54,360 Da, +/- 0.01%). Both disulfiram and prunetin inhibited rmALDH by >70% and >90%, respectively, but did not disrupt the quaternary structure of rmALDH. Furthermore, there was no detectable change within experimental error (+/- 0.01%) of the disulfiram or the prunetin homotetramers (Mr = approximately 217,448 Da and Mr = approximately 217,446 Da). This may possibly indicate that inhibition occurred via formation of intramolecular disulfide bond at the enzyme active site, or weak affinity noncovalent binding. In contrast, benomyl-inhibited rmALDH homotetramer (>90% inhibition) exhibited a Mr = approximately 217,650 Da (+/- 0.01%) corresponding to two butylcarbamoyl adducts on two of the four enzyme subunits. The skimmer-induced monomer afforded a mixture of unmodified rmALDH (Mr = approximately 54,365 Da, +/- 0.01%) and butylcarbamoylated enzyme (Mr = approximately 54,459 Da, +/- 0.01%). Finally, TPCK (>90% inhibition) modified all four subunits of rmALDH to give Mr = approximately 218,646 Da (+/- 0.01%). In all four cases while significant enzyme inhibition occurred, no destabilization of the quaternary complex was detected.


Subject(s)
Protein Structure, Quaternary/drug effects , Proteins/chemistry , Aldehyde Dehydrogenase/antagonists & inhibitors , Aldehyde Dehydrogenase/chemistry , Aldehyde Dehydrogenase/drug effects , Animals , Benomyl/pharmacology , Chromatography, Gel , Disulfiram/pharmacology , Enzyme Inhibitors/pharmacology , Isoflavones/pharmacology , Liver/enzymology , Online Systems , Protein Synthesis Inhibitors/pharmacology , Rats , Recombinant Proteins/chemistry , Spectrometry, Mass, Electrospray Ionization , Tosylphenylalanyl Chloromethyl Ketone/pharmacology
13.
Biochem Pharmacol ; 60(7): 947-53, 2000 Oct 01.
Article in English | MEDLINE | ID: mdl-10974203

ABSTRACT

The alcohol aversion therapy drug disulfiram has been shown to inhibit hepatic aldehyde dehydrogenase (ALDH), one of the key enzymes involved in ethanol metabolism. It is believed by some that disulfiram could be one of the active inhibitors in vivo. However, the actual interaction between disulfiram and ALDH remains ambiguous. We report here that when disulfiram inhibited recombinant rat liver mitochondrial ALDH (rlmALDH) in vitro, no significant molecular mass increase was detected during the first 30 min as determined by on-line HPLC-electrospray ionization mass spectrometry (LC-MS). This indicated that the inhibition in vitro was not caused directly by covalent adduct formation on the enzyme. We subsequently subjected both control and disulfiram-inhibited rlmALDH to Glu-C proteolytic digestion. LC-MS analysis of the Glu-C digestion of disulfiram-inhibited enzyme revealed that one peptide of M(r) = 4821, which contained the putative active site of the enzyme, exhibited a mass decrease of 2 amu as compared with the same peptide found in the Glu-C digestion of the control (M(r) = 4823). We believe that the loss of 2 amu indicated that inhibition of rlmALDH in vitro was due to formation of an intramolecular disulfide bond between two of the three adjacent cysteines in the active site, possibly via a very rapid and unstable mixed disulfide interchange reaction. Further confirmation of the intramolecular disulfide bond formation came from the fact that by adding dithiothreitol (DTT) we were able to recover partial enzyme activity. In addition, the peptide of M(r) = 4821 observed in the Glu-C digestion of the disulfiram-treated ALDH reverted to M(r) = 4823 after treatment with DTT, which indicated that the disulfide bond was reduced. We, thereby, conclude that disulfiram inhibited rlmALDH by forming an intramolecular disulfide, possibly via a fast intermolecular disulfiram interchange reaction.


Subject(s)
Aldehyde Dehydrogenase/antagonists & inhibitors , Disulfiram/pharmacology , Enzyme Inhibitors/pharmacology , Mitochondria, Liver/drug effects , Animals , Chromatography, Liquid , Dithiothreitol/pharmacology , Drug Interactions , Escherichia coli , Mass Spectrometry , Mitochondria, Liver/enzymology , Rats , Recombinant Proteins/antagonists & inhibitors , Serine Endopeptidases/metabolism
14.
Rapid Commun Mass Spectrom ; 14(10): 918-23, 2000.
Article in English | MEDLINE | ID: mdl-10825257

ABSTRACT

Disulfiram has been used clinically as an aversion therapy treatment for recovering alcoholics. One of its metabolites, S-methyl-N, N-diethylthiocarbamoyl sulfoxide (MeDTC-SO), is currently believed by some to be the active metabolite in vivo. We demonstrate in this report that MeDTC-SO is a potent irreversible inhibitor of recombinant rat liver mitochondrial aldehyde dehydrogenase (rlmALDH), the enzyme responsible for oxidizing acetaldehyde formed during ethanol metabolism. Recombinant rlmALDH was inhibited by MeDTC-SO after in vitro incubation with an IC(50) = 4.62 microM. The inhibition of rlmALDH was found to be accompanied by a concomitant increase of approximately 100 Da to the molecular mass of the native enzyme as determined by on-line high performance liquid chromatography (HPLC) electrospray ionization mass spectrometry (LC/MS), indicating that a covalent modification has occurred. To determine the site and structure of this covalent adduct, we developed a novel approach to characterize specific protein-drug interactions by linking a proteolytic enzyme digestion cartridge on-line with LC/MS. The on-line pepsin digestion LC/MS of MeDTC-SO-inhibited rlmALDH revealed an ion at MH(2)(2+) = 500.9, which was not present in the pepsin digestion of the non-inhibited enzyme. This peptide was tentatively attributed to the putative active site peptide (FNQGQC(301)C(302)C(303)) plus the adduct. This peptide was subjected to analysis by LC/MS/MS, which allowed us to determine that the covalent modification was associated with a single carbamoyl adduct at Cys-302, which has been shown to be the active site nucleophile of the enzyme.


Subject(s)
Aldehyde Dehydrogenase/analysis , Aldehyde Dehydrogenase/metabolism , Ditiocarb/analogs & derivatives , Mass Spectrometry/methods , Alcohol Deterrents/analysis , Alcohol Deterrents/metabolism , Alcohol Deterrents/pharmacology , Aldehyde Dehydrogenase/antagonists & inhibitors , Amino Acid Sequence , Animals , Chromatography, High Pressure Liquid/methods , Ditiocarb/analysis , Ditiocarb/metabolism , Ditiocarb/pharmacology , Enzyme Inhibitors/analysis , Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Humans , In Vitro Techniques , Pepsin A , Rats , Recombinant Proteins/analysis , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/metabolism , Sequence Analysis
15.
Proc Soc Exp Biol Med ; 214(2): 173-9, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9034136

ABSTRACT

C57 BL mice were injected daily with either saline or varied doses of cocaine (5-50 mg/kg), and thymocyte subpopulations were analyzed 4 hr after the fifth injection. Mice injected with either 25 or 50 mg/kg of cocaine showed a decrease in the percentage of CD4+8+ cells and increase of CD4-8-, CD4+, and CD8+ cells. The absolute numbers of each subpopulation, calculated by multiplying the percentage of each subpopulation with the total cell number, revealed an extensive decline in CD4+8+, a decrease in CD8+, an increase in CD4-8-, and no change in the CD4+ subpopulation. Flow cytometric analysis of thymocytes and electrophoresis of the thymocyte DNA revealed a dosage-dependent increase in cells undergoing programed cell death with apoptosis. Culturing of thymocytes from control or drug-treated mice demonstrated an inverse relationship between cell viability and cocaine concentrations, suggesting that in vivo cocaine, or its biological products, may damage thymocytes. Incubation of normal cells with cocaine showed a dose-dependent decrease of viability with identical patterns of the alteration of cell subpopulations observed in vivo. A dose-dependent increase of apoptosis was also observed. In summary, we demonstrate a selective in vivo cocaine-induced alteration of the thymocyte subpopulations and identified programed cell death with apoptosis as the likely mechanism mediating this thymic atrophy. The comparable findings observed in vivo and in vitro support the concept that cocaine may directly affect some features of thymocyte biology, and suggest the usefulness of the in vitro system in studying cocaine effects on thymocyte biology.


Subject(s)
CD4-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/drug effects , Cocaine/toxicity , Thymus Gland/cytology , Animals , Apoptosis/drug effects , CD4-CD8 Ratio/drug effects , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Cell Death/drug effects , Cell Survival/drug effects , Cells, Cultured , DNA/analysis , Dose-Response Relationship, Drug , Electrophoresis, Agar Gel , Flow Cytometry , Injections , Lymphocyte Count/drug effects , Male , Mice , Mice, Inbred C57BL , Thymus Gland/drug effects
16.
Immunogenetics ; 45(6): 365-70, 1997.
Article in English | MEDLINE | ID: mdl-9089093

ABSTRACT

Human immunoglobulin heavy chains are encoded by a highly complex locus, IGH, which encompasses many transcriptional units, including nine alternative constant region genes. Much of the constant region gene cluster was duplicated during hominoid evolution. In rodents, IGH is known to be regulated by multiple elements, including several enhancers 3' of the alpha chain-encoding A constant region gene, CA, the last transcribed region. Sequences downstream of the two human CA genes, possibly containing homologous enhancer elements, have not yet been reported. By long-range mapping of genomic DNA, a cluster of unmethylated rare restriction sites, representing a potential CpG island, was previously reported downstream of each CA gene, close to the 3' end of the duplicated region. Such potential CpG islands are candidates for additional IGH regulatory elements. We isolated bacteriophage clones containing these clusters of methylation-sensitive restriction sites, which lie within short CpG-rich stretches. Some of these sites showed tissue-specific methylation. 3' of the unmethylated CpG-rich sequences, clones derived from the 5' (telomeric) copy of the duplicated region, contained, in order, endogenous retroviral sequences, a processed ELK1 pseudogene, and the pseudogene IGHGP. Comparison with the presumed 3' (centromeric) copy of the duplicated region showed that similarity was lost exactly at the end of the retroviral long terminal repeat sequences. These results imply that an endogenous retroviral integration was present immediately 3' of IGH in the common hominoid ancestor and suggest models for the duplication of the region.


Subject(s)
Chromosome Mapping , CpG Islands/genetics , Immunoglobulin Heavy Chains/genetics , Sequence Analysis, DNA , Base Sequence , Genome, Human , Humans , Molecular Sequence Data , Sequence Alignment
17.
Am J Pathol ; 149(2): 675-85, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8702005

ABSTRACT

T lymphocytes and monocyte/macrophages are prominent components of atherosclerotic lesions, and many of these cells are activated and secreting cytokines. To determine the role of these cells in the pathogenesis of atherosclerosis, we studied its development in T-cell-deficient mice fed a high fat atherogenic diet. Depleting euthymic mice of their CD4+ lymphocytes by 20 weekly injections of CD4 monoclonal antibodies reduced the mean area of their aortic lesions by approximately 70%. Similarly, the mean lesion area of T-cell-deficient nude (nu/nu) mice was 10% of the size of that of their heterozygote (nu/+) litter mates. Flow cytometric studies of splenic T cells and analyses of serum total and HDL cholesterol of these mice indicated that the differences in mean lesion areas among the experimental groups were most closely correlated with differences in splenic T cells content. These studies suggest that in these two models T lymphocytes contribute to the pathogenesis of early atherosclerotic lesions and that a further understanding of this phenomenon may provide future approaches toward the prevention and treatment of the disease.


Subject(s)
Arteriosclerosis/immunology , CD4-Positive T-Lymphocytes/immunology , Hyperlipidemias/complications , Animals , Antibodies, Monoclonal/pharmacology , Aorta/drug effects , Aorta/pathology , Arteriosclerosis/pathology , Arteriosclerosis/prevention & control , CD4-Positive T-Lymphocytes/pathology , Cell Death/immunology , Cholesterol/blood , Cholesterol, HDL/blood , Cytotoxicity, Immunologic , Disease Models, Animal , Female , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Nude , Triglycerides/blood
18.
Genomics ; 35(1): 109-17, 1996 Jul 01.
Article in English | MEDLINE | ID: mdl-8661111

ABSTRACT

Despite several lines of evidence suggesting that common chromosomal fragile sites are biologically important as hot spots for recombination, their structure remains unknown. We showed previously that the plasmid pSV2neo preferentially integrates into bands containing fragile sites in cells transfected under conditions of fragile site induction. Here we report the isolation and characterization of the DNA sequences from two such independent integrations into 3p14.2, a common fragile site (FRA3B). These FRA3B region sequences were shown to lie within a 1330-kb YAC, 850A6, approximately 350 kb telomeric of the breakpoint of t(3;8), a constitutional rearrangement. The two integration sites are 10 kb apart, but each integration is associated with a deletion. We have constructed a partial genomic contig of the integration sites and deleted regions spanning approximately 85 kb. Analysis of the DNA sequences immediately surrounding the plasmid integrations revealed no known coding sequences or repeat structures resembling the (CGG)n motif characteristic of the rare fragile sites. In addition, by Southern blotting analysis, none of the phage clones isolated from the FRA3B region were found to contain CGG repeats. Fluorescence in situ hybridization analysis of genomic clones from this contig to metaphase cells induced to express breaks demonstrated hybridization adjoining the chromosome breaks, and occasionally the hybridization signal spanned the break. The results imply that breakage occurs at variable positions within a large region (at least on the order of 85 kb). Together, these data suggest that the structure of FRA3B differs from that of rare fragile sites.


Subject(s)
Chromosome Fragility , Chromosomes, Human, Pair 3/genetics , DNA/genetics , Aphidicolin/pharmacology , Base Sequence , Blotting, Southern , Chromosome Fragile Sites , Chromosome Walking , Chromosomes, Artificial, Yeast/genetics , Chromosomes, Human, Pair 3/drug effects , Cloning, Molecular , Electrophoresis, Gel, Pulsed-Field , Enzyme Inhibitors/pharmacology , Genetic Vectors/genetics , Humans , In Situ Hybridization, Fluorescence , Molecular Sequence Data , Nucleic Acid Synthesis Inhibitors , Recombination, Genetic , Sequence Deletion , Trinucleotide Repeats
20.
Int J Immunopharmacol ; 16(4): 311-9, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8045671

ABSTRACT

Cocaine dosages ranging from 2.5 mg/kg/day to a highly toxic dose of 50 mg/kg/day were injected intramuscularly or intraperitoneally into different groups of mice for 4-10 days. The effects of cocaine were evaluated by tumor growth, lymphocyte transformation, phagocytosis, and IgM plaque-forming cells. At all dosages, including toxic doses, cocaine does not inhibit lymphocyte transformation of the splenic or the peripheral blood lymphocytes. However, all other immunological parameters of the same animal were suppressed. These results suggest that lymphocyte transformation may not be a proper indicator for the immune status of mice treated with cocaine. The same may be true when testing human drug abusers.


Subject(s)
Adjuvants, Immunologic/pharmacology , Cocaine/pharmacology , Immunity, Cellular/drug effects , Lymphocyte Activation/drug effects , Animals , Biomarkers , Erythrocytes/immunology , Flow Cytometry , Hemolytic Plaque Technique , Immunoglobulin M/immunology , In Vitro Techniques , Mice , Mice, Inbred C57BL , Mitogens/pharmacology , Neoplasm Transplantation , Phagocytosis/drug effects , Plasmacytoma/immunology , Spleen/cytology , Spleen/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...